Is DaVita Inc. (DVA) A Good Stock To Buy?

We came crossed a bullish thesis connected DaVita Inc. connected Roche Capital’s Substack by Pedro Ortiz. In this article, we volition summarize the bulls’ thesis connected DVA. DaVita Inc.'s stock was trading astatine $154.79 arsenic of March 4th. DVA’s trailing and guardant P/E were 16.01 and 11.36 respectively according to Yahoo Finance.

hywards/Shutterstock.com

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney nonaccomplishment successful the United States. DVA ended 2025 arsenic a highly profitable but structurally challenged healthcare company, generating $12.9 cardinal successful gross with humble 0.6% integrated maturation and adjusted operating nett of $2.094 billion.

Despite maintaining beardown fiscal prime and an adjusted operating borderline of astir 16.2%, the halfway situation for DaVita is the deficiency of diligent measurement growth, arsenic dialysis treatments declined by 1.1% during the year. Because the dialysis exemplary is fundamentally based connected treatments performed, this diminution straight pressures gross and profitability.

The company’s U.S. dialysis part remains its backbone, with gross maturation successful 2025 driven chiefly by a 4.7% summation successful gross per attraction alternatively than higher diligent volumes. Management believes that objective initiatives targeting diligent mortality—such arsenic accrued vaccination rates, the adoption of GLP-1 drugs similar semaglutide, precocious dialysis technologies, and improved attraction coordination—could yet reconstruct astir 2% yearly measurement growth, but the benefits whitethorn not afloat materialize until astir 2029.

While the Integrated Kidney Care (IKC) conception turned profitable successful 2025 with $22 cardinal successful operating profit, its advancement mostly reflects improved show successful value-based contracts alternatively than meaningful measurement expansion, suggesting constricted maturation potential. DaVita is besides pursuing strategical initiatives specified arsenic a $200 cardinal number concern successful Elara Caring, a large U.S. location healthcare provider, aimed astatine improving diligent outcomes, reducing hospitalizations, and strengthening integrated attraction capabilities.

However, the concern thesis remains uncertain due to the fact that occurrence depends heavy connected objective outcomes alternatively than accepted operational improvements. Although DaVita continues to make beardown escaped currency travel of astir $1 cardinal annually and aggressively repurchases shares, overmuch of its projected EPS maturation stems from buybacks alternatively than underlying concern expansion. As a result, DaVita represents a financially beardown but fundamentally antiaircraft concern wherever semipermanent show depends connected whether objective initiatives tin reverse declining diligent volumes.